 |
|
Toxic Effects Associated With the Administration of Deferoxamine in the Premature Baboon With Hyaline Membrane Disease
Robert A. deLemos, MD;
Robert J. Roberts, MD;
Jacqueline J. Coalson, PhD;
James A. deLemos;
Donald M. Null, Jr, MD;
Dale R. Gerstmann, MD
Am J Dis Child. 1990;144(8):915-919.
Abstract
• We hypothesized that administration of the iron chelator deferoxamine would inhibit iron-catalyzed free radical generation and lessen the severity of oxygeninduced pulmonary injury. To evaluate its efficacy and safety in premature infants, we administered deferoxamine by intravenous infusion to five premature baboons with hyaline membrane disease supported with conventional ventilation and 100% oxygen for 6 days. Seven animals served as controls. Deferoxamine treatment was initiated at 10 mg/kg per hour but, after the precipitous death of the first animal, was progressively reduced to 1.25 mg/kg per hour in the other animals. Four of five deferoxamine-treated baboons developed cardiovascular collapse and all five died by 42 hours. Five of the seven control animals survived the 6-day expermental period. Since cardiovascular toxic effects have not previously been reported, these findings suggest unique vulnerability of the immature cardiovascular system to iron chelation.
(AJDC. 1990;144:915-919)
Author Affiliations
From the Department of Physiology and Medicine, Southwest Foundation for Biomedical Research, San Antonio, Tex (Drs deLemos and Gerstmann and Mr deLemos); Department of Pediatrics, University of Virginia School of Medicine, Charlottesville (Dr Roberts); Department of Pathology, University of Texas Health Science Center, San Antonio (Dr Coalson); and Neonatology Division, Wilford Hall USAF Medical Center, San Antonio (Dr Null).
Footnotes
Accepted for publication December 18, 1989.
Reprint requests to Department of Physiology and Medicine, Southwest Foundation for Biomedical Research, PO Box 28147, San Antonio, TX 78284 (Dr deLemos).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
HIF stabilizing agents: shotgun or scalpel?
Asikainen and White
Am. J. Physiol. Lung Cell. Mol. Physiol. 2007;293:L555-L556.
FULL TEXT
Loss of lung mitochondrial aconitase activity due to hyperoxia in bronchopulmonary dysplasia in primates
Morton et al.
Am. J. Physiol. Lung Cell. Mol. Physiol. 1998;274:L127-L133.
ABSTRACT
| FULL TEXT
Role of Iron in Reoxygenation Injury of Postischemic Skeletal Muscle
Kirschner and Fantini
PERSPECT VASC SURG ENDOVASC THER 1992;5:69-83.
|
